GlassScriptPrepare for your visit
Ellen B Valadez
Neurology (Psychiatry & Neurology) · Chattanooga, TN · NPI 1821313107
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$11,874.42
in general payments reported to CMS, 2019-2025 · $2,757 in 2025
The $2,757 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $2,601.34
- Teva Pharmaceuticals USA, INC. $2,246.72
- Mdd US Operations, LLC $859.90
- Biohaven Pharmaceuticals, INC. $500.76
- Ucb, INC. $464.06
- Neurocrine Biosciences, INC. $341.23
Drugs and devices associated with these payments
Austedo Xr Qulipta Ubrelvy Botox Gocovri Ingrezza Valtoco Epidiolex Vyepti Radicava Amvuttra Nuplazid
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Ellen Valadez listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1392061/ellen-b-valadez